Account
WatConsult Lybrates IICE Vodka; wins over Indraprastha
MUMBAI: A company is known by the accounts it handles! WatConsult, the digital arm of Dentsu Aegis Network, has expanded its Delhi operations. It has added five accounts to its portfolio by winning the digital and social media mandate of IICE Vodka, Lybrate, Centre for Digital Financial Inclusion (CDFI), Indraprastha Apollo Hospitals and Boston Scientific Corporation of India (BSCI).
Indraprastha Apollo Hospitals and CDFI were both multi-agency pitches whereas IICE Vodka is a part of Jagatjit Industries which recently launched two new flavours besides the plain vodka: Green Apple and Kinky Chilli. WatConsult will be managing the social and digital mandate of these brands, including their online community Pouritout.com.
For Lybrate, the agency will be handling the social media presence, whereas, for BSCI, the agency will be handling the digital and social media duties.
WatConsult founder and CEO Rajiv Dingra said, “After expanding our Mumbai office, we are now focussing on expanding and building our Delhi operations. Our new office is set up to accommodate a team of 100+ people. We are glad these brands believed in us and our work, and gave us an opportunity to work with them. We look forward to serve them diligently and whole-heartedly.”
WatConsult has also strengthened its team with a staff of 250 and has also moved to a larger office in Delhi.
“We are very excited to work with these new clients. The team has come up with some extraordinary ideas and we look forward to implementing them and launch great digital campaigns,” added WatConsult AVP operations Faisal Haq.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
